Safety of long-acting beta-agonists--an urgent need to clear the air.
Martinez
Fernando D
FD
Arizona Respiratory Center, University of Arizona College of Medicine, Tucson, USA.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000009:adverse effects* / Q000627:therapeutic use; D000068759:Formoterol Fumarate; D006801:Humans; D000068299:Salmeterol Xinafoate; D006113:United Kingdom; D014481:United States
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate